Day: May 13, 2021

RMK Property Holdings MapRMK Property Holdings MapST. JOHN’S, Newfoundland and Labrador, May 13, 2021 (GLOBE NEWSWIRE) — Red Moon Resources Inc. (the “Company” or “Red Moon” – TSXV: RMK) is pleased to provide the following corporate update: Highlights:Red Moon will be proposing a name change, to be presented to shareholders at a special AGM slated for July, 2021; The name change will better reflect the Company’s core business (potential supplier of high-grade salt for North American de-icing markets) as it advances its Great Atlantic Salt Project in western Newfoundland through the Feasibility Stage; To create a pure North American salt focus and unlock the value of other assets within the Company to the maximum benefit of shareholders, Red Moon is weighing various strategic options beginning with a planned...

Wellteq (CSE.WTEQ) (OTC.WTEQF) signs letter of intent (LOI) detailing the general terms of a strategic partnership agreement with Frontier Wellness Management and its operating subsidiary Apotheek Pharma Consulting (FW-APC). FW-APC are focused on marketing health and wellness solutions into their unique network of 140,000 medical professionals in the healthcare, pharmacy, and pharmaceutical markets in Spain. Under the expected terms of a formal strategic partnership agreement, FW-APC will pay an initial EUR100,000 to Wellteq which will be expended on localization, further development, and integration. It is expected that Wellteq will be paid by each customer in accordance with their Software-as-a-Service (SaaS) user pricing. Working with Wellteq’s sales and marketing personnel, FW-APC will immediately initiate marketing of the Wellteq...

IRVINE, CA, May 13, 2021 (GLOBE NEWSWIRE) —  Odyssey Group International, Inc. (OTCQB:ODYY) (the “Company” or “Odyssey”),a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to welcome Ricky Richardson to the Company’s Board of Directors.   Mr. Richardson has over 30 years of experience as a global operations and quality leader. He possesses operations and quality control experience that includes change management, multi-plant operations, financial management, supply chain/vendor management, strategic business development, start-up planning and execution, new product introductions and lean deployment. Mr. Richardson held positions at Danaher Corporation, a multi-billion dollar global manufacturer of Diagnostic, Life Sciences, Product Identification,...

– Safety and efficacy study for macimorelin initiated as agreed with U.S. FDA and the European Medicines Agency (“EMA”) in the Company’s Pediatric Investigation Plan (“PIP”) – Patient enrollment on track to start this quarter – Planned completion of pivotal Phase 3 study expected in Q3 2022 CHARLESTON, S.C., May 13, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced the commencement of its pivotal Phase 3 safety and efficacy study AEZS-130-P02 (“the DETECT-trial”) evaluating macimorelin for the diagnosis of childhood-onset growth hormone deficiency (“CGHD”). The investigational new drug application...

Phase 3 study of lenabasum in dermatomyositis on schedule for topline data in Q2 2021 Company focused on advancing cannabinoid programs in metabolic diseases and cancer into the clinic in 2022 Corbus is actively engaging with potential partners to expand its pipeline through acquisition of external assets Cash and investments on hand of $125M provides projected runway into Q1 2024Norwood, MA, May 13, 2021 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today reported financial results for the first quarter of 2021 and provided corporate updates. Pipeline Updates:Lenabasum, a novel, oral, selective cannabinoid receptor type 2 (CB2) agonist:Dermatomyositis: The...

MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes plasma atomized metal powders, environmentally friendly plasma waste-to-energy systems and clean plasma torch products, is pleased to announce that, further to significant inquiries from shareholders, it will release its 2021 first quarter results on May 17th, 2021, before markets open. Separately, and further to its press release dated March 3rd, 2021 (wherein it was disclosed that PyroGenesis almost doubled its manufacturing footprint by leasing an additional 31,632 sq. ft), the Company is now pleased to announce the successful installation of approximately $1MM in...

WASHINGTON, May 13, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that Senior Managing Directors Paul Braithwaite, Brian Carl and Wendy Shapss and Managing Directors Romy Comiter and Ian Marshall have been named to the Who’s Who Legal: Insurance & Reinsurance 2021 list. In addition, Mr. Braithwaite and Mr. Marshall were named Global Elite Thought Leaders for Insurance & Reinsurance, a recognition for only the top 2% of all nominees. These experts received the highest number of nominations from peers. Mr. Braithwaite, based in New York, is Co-Leader of the Global Insurance Services practice and has over 30 years of industry experience. He is an expert in actuarial science, underwriting, insurance and reinsurance company management. Mr. Carl, based in Chicago, is a member of the Data & Analytics...

Raised net proceeds of $27.9 million in U.S. initial public offering in February 2021 Lead programs EVX-01 and EVX-02 on track for Phase 1/2a data readouts late in Q2 Product candidates EVX-03 and EVX-B1 progressing through pre-clinical development Cash reserves of $27 million at March 31, 2021COPENHAGEN, Denmark, May 13, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer, bacterial diseases and viral infections, announced today the first quarter 2021 financial results and provided an operational update. Lars Wegner, CEO of Evaxion, said: “Evaxion made strong progress in Q1 2021, successfully concluding our U.S. IPO and continuing to advance our...

SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the Cowen 2nd Annual Virtual Oncology Innovation Summit. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to present in a virtual fireside chat on Thursday, May 20, 2021 at 10:20 a.m. PT / 1:20 p.m. ET. A live audio webcast of the presentation will be available in the Investors section of Kura’s website at www.kuraoncology.com, with a replay available shortly after the live event. About Kura Oncology Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s...